A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: The Atherosclerosis Risk in Communities (ARIC) Study

Diabetes Care

Volumn 20, Issue 6, 1997, Pages 935-942

  Folsom, Aaron R ^a   Szklo, Moyses ^c   Stevens, June ^d   Liao, Fangzi ^a   Smith, Robert ^e   Eckfeldt, John H ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d Mississippi Family Health Center ^*  (United States)

^e Mississippi Family Health Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; CORONARY RISK; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RACE DIFFERENCE; SEX DIFFERENCE;

EID: 0030973422     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.6.935     Document Type: Article

References (51)

1. Wingard DL, Barrett-Connor E: Heart disease and diabetes. In Diabetes in America. 2nd ed. Bethesda, MD, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, 1995, p. 429-548 (NIH publ. no. 95-1468)
2. Stamler R, Stamler J: Asymptomatic hyperglycaemia and coronary heart disease: a series of papers by the International Collaborative Group based on studies in 15 populations: joint discussion. J Chron Dis 32:829-837, 1979
3. Cruz-Vidal M, Garcia-Palmieri MR, Costas R, Sorlie PD, Havlik RJ: Abnormal blood glucose and coronary heart disease: the Puerto Rico Heart Health Program. Diabetes Care 6:556-561, 1983
4. Park S, Barren-Connor E, Wingard DL, Shan J, Edelstein S: GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes: The Rancho Bernardo Study. Diabetes Care 19:450-456, 1996
5. Scheidt-Nave C, Barrett-Connor E, Wingard DL, Cohn BC, Edelstein SL: Sex differences in fasting glycemia as a risk factor for ischemic heart disease death. Am J Epidemiol 133:565-576, 1990
6. Donahue RP, Abbott RD, Reed DM, Yano K: Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry: Honolulu Heart Program. Diabetes 36:689-692, 1987
7. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, Stamler R, Smith D, Collette P, Stamler J: Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 123:504-516, 1986
8. Jarrett RJ, McCartney P, Keen H: The Bedford Survey: ten year mortality rates in newly diagnosed diabetes, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 22:79-84, 1982
9. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall Study. Br Med J 287:867-870, 1983
10. Eschwege E, Ducimetiere P, Papoz L, Claude JR, Richard JL: Blood glucose and coronary heart disease. Lancet ii:472-473, 1980
11. Perry IJ, Wannamethee G, Whincup PH, Shaper AG: Asymptomatic hyperglycaemia and major ischaemic heart disease events in Britain. J Epidemiol Community Health 48:538-542, 1994
12. Yamell JW, Pickering JE, Elwood PC, Baker IA, Bainton D, Dawkins C, Phillips DI: Does nondiabetic hyperglycemia predict future IHD? Evidence from the Caerphilly and Speedwell studies. J Clin Epidemiol 47:383-388, 1994
13. Butler WJ, Ostrander LD Jr, Carman WJ, Lamphiear DE: Mortality from coronary heart disease in the Tecumseh Study: long-term effect of diabetes mellitus, glucose intolerance, and other risk factors. Am J Epidemiol 121:541-547, 1985
14. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
15. Laakso M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965, 1993
16. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless LE, Barnes RW, Cram KB, Hutchinson RG, and the Atherosclerosis Risk in Communities (ARIC) Study Investigators: Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke 25:66-73, 1994
17. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R, for the IRAS Investigators: Insulin sensitivity and atherosclerosis. Circulation 93:1809-1817, 1996
18. Welborn TA, Knuiman MW, Ward N, Whittall DE: Serum insulin is a risk marker for coronary heart disease mortality in men but not in women. Diabetes Res Clin Prac 26:51-59, 1994
19. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M: Hyperinsulinemic microalbuminuria: a new risk indicator for coronary heart disease. Circulation 91:831-837, 1995
20. Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
21. The ARIC Investigators: The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 129:687-702, 1989
22. Jackson R, Chambless LE, Yang K, Byrne T, Watson R, Folsom A, Shahar E, Kalsbeek W, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators: Differences between respondents and nonrespondents in a multicenter community-based study vary by gender and ethnicity. J Clin Epidemiol 49:1441-1446, 1996
23. Eckfeldt JH, Chambless LE, Shen YL: Short-term, within-person variability in clinical chemistry test results: experience from the Atherosclerosis Risk in Communities Study. Arch Pathol Lab Med 118:496-500, 1994
24. Siedel J, Hegele EO, Ziegenhorn J, Wahlefeld AW: Reagent for the enzymatic determination of total serum cholesterol with improved lipolytic efficiency. Clin Chem 29:1075-1080, 1983
25. Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, Gruber W: Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem 22:165-174, 1984
26. 2+ precipitation (Abstract). Clin Chem 28:1574, 1982
27. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
28. Clauss A: Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17:237-246, 1957
29. Baecke JAH, Burema J, Frijters JER: A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936-942, 1982
30. Rose GA, Blackburn H, Gillum RF, Prineas RJ: Cardiovascular Survey Methods. 2nd ed. Basel, Switzerland, World Health Organization, 1982 (WHO monogr. no. 56)
31. White AD, Folsom AR, Chambless LE, Sharrett AR, Yang K, Conwill D, Higgins M, Williams OD, Tyroler HA: Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol 49:223-233, 1996
32. Prineas RJ, Crow RS, Blackburn H: The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. Littleton, MA, John Wright, 1982
33. Rautaharju PM, Warren JW Jain U, Wolf HK, Nielsen CL: Cardiac infarction injury score: an electrocardiographic coding scheme for ischemic heart disease. Circulation 64:249-256, 1981
34. Nabulsi AA, Folsom AR, Heiss G, Weir SS, Chambless LE, Watson RL, Eckfeldt JH, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators: Fasting hyperinsulinemia and cardiovascular disease risk factors in nondiabetic adults: stronger associations in lean versus obese subjects. Metabolism 44:914-922, 1995
35. Temple RC, Carrington CA, Luzio SD: Insulin deficiency in non-insulin-dependent diabetes. Lancet 1:293-295, 1989
36. Haffner SM, D'Agostino RB Jr, Saad MF, Rewers M, Mykkänen L, Selby J, Howard G, Savage PJ, Hamman R, Wagenknecht LE, Bergman RN: Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared to non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Diabetes 45:742-748, 1996
37. Keil JE, Sutherland SE, Knapp RG, Lackland DT, Gazes PC, Tyroler HA: Mortality rates and risk factors for coronary disease in blacks as compared with white men and women. N Engl J Med 329:73-78, 1993
38. Bierman EL: Atherogenesis in diabetes. Arterioscler Thromb 12:647-656, 1992
39. Pyörälä K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 3:463-524, 1987
40. Getz GS: Report on the Workshop on Diabetes and Mechanisms of Atherogenesis: 9/17-18, 1992. Arteriosder Thromb 12:459-464, 1993
41. Jarrett RJ: Why is insulin not a risk factor for coronary heart disease? Diabetologia 37: 945-947, 1994
42. Reaven GM, Laws A: Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia 37:948-952, 1994
43. Stem MP: The insulin resistance syndrome: the controversy is dead, long live the controversy! Diabetologia 37:956-958, 1994
44. Wingard DL, Barrett-Connor EL, Ferrara A: Is insulin really a heart disease risk factor? Diabetes Care 18:1299-1304, 1995
45. McKeigue P, Davey G: Associations between insulin levels and cardiovascular disease are confounded by comorbidity. Diabetes Care 18:1294-1298, 1995
46. Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati FL, Sharrett AR, Davis CE, Heiss G: Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Metabolism 45:699-706, 1996
47. Robbins DC, Andersen L, Bowsher R, Chance R, Dinesen B, Frank B, Gingerich R, Goldstein D, Widemeyer HM, Haffner S, Hales CN, Jarett L, Polonsky K, Porte D, Skyler J, Webb G, Gallagher K: Report of the American Diabetes Association's Task Force on Standardization of the Insulin Assay. Diabetes 45:242-256, 1996
48. Båvenholm P, Proudler A, Tornvall P, Godsland I, Landou C, de Faire U, Hamsten A: Insulin, intact and split proinsulin, and coronary artery disease in young men. Circulation 92:1422-1429, 1995
49. Kenny SJ, Aubert RE, Geiss LS: Prevalence and incidence of non-insulin-dependent diabetes. In Diabetes in America. 2nd ed. Bethesda, MD, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, 1995, p. 47-67 (NIH publ. no. 95-1468)
50. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL: Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys 1960-1991. JAMA 272:205-211, 1994
51. Lowe LP, Liu K, Greenland P, Metzger BE, Dyer AR, Stamler J: Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men: the Chicago Heart Association Detection Project in Industry Study. Diabetes Care 20:163-169, 1997